ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,577Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 2094

$762K Total Retail Price of All Prescriptions

Rank: 199 out of 2094

349 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 7,787 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 368 286 1 3
FUROSEMIDE 327 293 2 6
WARFARIN SODIUM 316 245 3 11
FAMOTIDINE 284 230 4 34
AMLODIPINE BESYLATE 274 225 5 2
OMEPRAZOLE 264 146 6 4
POTASSIUM CHLORIDE 263 196 7 24
METOPROLOL TARTRATE 255 200 8 10
CYMBALTA 246 168 9 61
SIMVASTATIN 226 191 10 1
IPRATROPIUM-ALBUTEROL 199 153 11 92
POLYETHYLENE GLYCOL 3350 186 78 12 75
CARVEDILOL 180 167 13 19
ATORVASTATIN CALCIUM 173 80 14 5
OXYCODONE-ACETAMINOPHEN 159 133 S2 15 40
LEVETIRACETAM 151 42 16 78
BUDESONIDE 149 120 10 17 228
OLANZAPINE 141 74 18 113
FENTANYL 139 96 S2 19 68
CLOPIDOGREL 137 121 20 22
MIRTAZAPINE 134 112 21 43
METOPROLOL SUCCINATE 133 114 22 9
DIVALPROEX SODIUM ER 126 29 23 179
DONEPEZIL HCL 121 114 24 20
NAMENDA 116 110 25 32
PANTOPRAZOLE SODIUM 115 58 26 37
PREDNISONE 111 83 27 54
DIVALPROEX SODIUM 111 16 27 69
NITROGLYCERIN PATCH 110 93 29 101
RISPERIDONE 99 48 30 56
PRANDIN 96 96 31 125
LYRICA 95 74 32 85
TAMSULOSIN HCL 93 82 33 29
LISINOPRIL 93 71 33 7
CLONIDINE HCL 89 76 35 62
LIDODERM 85 71 36 59
AMOX TR-POTASSIUM CLAVULANATE 85 61 36 107
LAMOTRIGINE 84 12 38 177
ABILIFY 82 23 39 165
PLAVIX 81 59 40 38
ALBUTEROL SULFATE 77 63 41 90
GABAPENTIN 76 36 42 23
FLUTICASONE PROPIONATE 75 60 43 41
LANTUS 74 65 44 66
NOVOLIN R 70 67 45 214
LACTULOSE 70 64 45 65
SERTRALINE HCL 70 47 45 26
ESCITALOPRAM OXALATE 65 51 48 46
CARBAMAZEPINE XR 65 12 48 337
QUETIAPINE FUMARATE 65 19 48 71
SINGULAIR 64 53 51 64
FINASTERIDE 62 53 52 97
CITALOPRAM HBR 61 0 53 47
ROPINIROLE HCL 58 58 54 235
KLOR-CON M20 57 35 55 106
LEVOFLOXACIN 56 45 56 70
CARBAMAZEPINE 55 0 57 206
PRAVASTATIN SODIUM 55 43 57 18
ENULOSE 55 11 57 303
IPRATROPIUM BROMIDE 55 55 57 169
OXYCONTIN 55 31 S2 57 98
ALENDRONATE SODIUM 50 23 62 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.